S2 Ep22: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?
About this episode
This episode discusses the potential of GLP-1 therapy in treating chronic skin conditions with insights from dermatologist Daniel Walker.
In this episode, board-certified dermatologist of US Dermatology Partners, Daniel Walker, MD, FAAD, shares emerging insights into the expanding role of GLP-1 receptor agonists beyond their primary use in diabetes and weight loss, highlighting their promising—yet still investigational—impact on inflammatory skin diseases such as psoriasis and HS.
More episodes of The Cutaneous Connection
- S2 Ep23: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis
- S2 Ep21: By the Skin of Your Teeth with The Spizuoco Sisters
- S2 Ep20: Skin Changes, Hormones, and the Menopause Conversation in Aesthetics
- S2 Ep19: Highlighting Voices of Patients With Indolent Systemic Mastocytosis
- 19: Utilizing the National Eczema Association's EczemaWise App for Clinicians and Patients
- S2 Ep18: ‘A Hairtoric Moment’: Advocating for ICD-10 Codes in Scarring Alopecia
Explore listener stats, chart rankings, contacts and more on the The Cutaneous Connection podcast page.